Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 
GREENVILLE, N.C., Aug. 14, 2017 -- Carolina Vision Care announced the arrival of new technology for diagnosing dry eye. Dry eye is a condition where a person's eyes either do not produce enough natural tears, or where the eyes do not produce the correct components of tears needed to adequately lubricate the eye. This results in irritation, a feeling of sandiness in the eye, and can be a precursor to more frequent eye infections. Prompt and proper diagnosis allows treatment to begin sooner and possibly prevent further problems.
Diagnosis of dry eye is sometimes difficult because most current methods simply measure tear production. In the early stages of the condition, the total production of tears often seems to be normal, at least in terms of volume, so these tests are misleading. Carolina Vision Care has therefore added a new diagnostic test to its arsenal to better serve its dry eye patients.
InflammaDry, a diagnostic test, measures markers of inflammation on the surface of the eye rather than tear production. Inflammation often results from dry eye, but it can also be a cause of it. In either case, there is a strong correlation between the two.
"People with dry eye disease consistently have higher levels of an inflammatory marker called MMP-9. The new test looks specifically for this marker. InflammaDry only takes four steps to get the results, which are derived by examining tear fluid from the patient. Best of all, it has an 85 percent sensitivity, meaning that it will catch the vast majority of cases in one test. The results allow us to tailor a treatment plan unique for the individual patient," explained Dr. Thomas C. McIntosh, of Carolina Vision Care.
InflammaDry a single use, noninvasive, disposable test that detects for inflammation in the tears. After the results are in, the doctor will inform the patient and recommend a custom treatment plan exclusive to the particular patient. Typically, results are obtained during the same visit so there is no need to wait and wonder.
About Carolina Vision Care
Carolina Vision Care is family owned and operated providing comprehensive eye care for patients of all ages in Eastern North Carolina. Convenient appointment times are available Monday through Friday.
For more information visit www.carolinavisioncare.com.
Carolina Vision Care 1804 W. Arlington Blvd Greenville, NC 27834 (252) 755-0290
